Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
05/27/2009 | CN100490881C Preparation method of food-digesting spleen-invigorating oral liquid containing micrometer chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder, pine pollen powde |
05/27/2009 | CN100490872C Kidney tonifying oral liquid made of American ginseng and cordyceps |
05/27/2009 | CN100490869C Formulation with six ingredients containing rehmanniae |
05/27/2009 | CN100490864C Yin-nourishing fatigue-relieving capsules |
05/27/2009 | CN100490863C Preparing process of antiphlogistic Chunwang capsule |
05/27/2009 | CN100490862C Preparation method of intestine-moistening face-beautifying granule and capsule with micron pine pollen, cactus, ganoderma lucidum and wolfberry fruit powder |
05/27/2009 | CN100490861C Preparation method of liver-benefiting face-beautifying wine with micron pine pollen and pearl powder for women |
05/27/2009 | CN100490860C Preparation method of liver-benefiting face-beautifying oral liquid with micron pine pollen and pearl powder for women |
05/27/2009 | CN100490849C Method for preparing houttuynia freeze-dried powder injection |
05/27/2009 | CN100490846C Medicine for improving sleep and nourishing bowel and relieving constipation and its preparation |
05/27/2009 | CN100490845C Herbal composition and its use in chemotheraphy |
05/27/2009 | CN100490834C Preparation method of kidney-tonifying fatigue-eliminating oral liquid containing micropilose antler, safflower seeds etc. |
05/27/2009 | CN100490832C Method for preparing kidney-warming face-nourishing liquor containing micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus, safflower etc. |
05/27/2009 | CN100490831C Method for preparing kidney-warming face-nourishing oral liquid containing micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus, safflower etc. |
05/27/2009 | CN100490829C Selenium-rich hedgehog fungus extract preparation for treating colitis, gastritis and stomach cancer and its preparing process |
05/27/2009 | CN100490823C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
05/27/2009 | CN100490821C New use of tremella heteropolysaccharide or its extract |
05/27/2009 | CN100490811C Piperazine derivative used as CCRS antagonist |
05/27/2009 | CN100490806C Oral dispersion domperidone coutrolled-release gel and its preparing method |
05/27/2009 | CN100490798C Quick disintegrated tablet or oral cavity disintegrated tablet containing L-glutamic acid and azulene sodium sulfonate and making method thereof |
05/27/2009 | CN100490792C Use of Teroo hydrochloride and its chemical analog in preparation of anti-liver fibrotic medicine |
05/27/2009 | CN100490790C Enteric coated omeprazole pellets capsule and the preparing method thereof |
05/27/2009 | CN100490777C Chinese medicinal tooth-strengthening powder for treating dental disease and its manufacturing method |
05/27/2009 | CN100490776C Oral compositions providing optimal surface conditioning |
05/27/2009 | CN100490659C Method for preparing bowel-lubricating, face-beautifying yoghurt with micron pine pollen, cactus powder, glossy ganoderma powder and medlar |
05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
05/26/2009 | US7538121 Vanilloid receptor modulators |
05/26/2009 | US7538118 6-aminomorphinane derivatives, method for production and use thereof |
05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
05/26/2009 | CA2497857C Novel p-selectin ligand protein |
05/26/2009 | CA2494165C Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
05/26/2009 | CA2463264C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
05/26/2009 | CA2367017C Inhibitors of impdh enzyme |
05/26/2009 | CA2345100C Optimized use of 6-mercaptopurine drug in the treatment of immune-mediated gastrointestinal disorders |
05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
05/26/2009 | CA2334773C Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
05/26/2009 | CA2295936C Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
05/26/2009 | CA2091102C Microsomal triglyceride transfer protein |
05/22/2009 | WO2009064819A2 Compositions for the treatment of gastrointestinal inflammation |
05/22/2009 | WO2009064460A2 Gastrointestinal delivery systems |
05/22/2009 | WO2009064458A2 Compositions for the treatment of inflammation of the gastrointestinal tract |
05/22/2009 | WO2009064417A2 Compositions for the treatment of gastrointestinal inflammation |
05/22/2009 | WO2009064156A1 Novel composition obtained from labisia pumila extract for hepatoprotective activity |
05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
05/22/2009 | WO2009063992A1 Condensed pyridine derivative and use thereof |
05/22/2009 | WO2009063991A1 Pyridooxazepine derivative and use thereof |
05/22/2009 | WO2009063990A1 Benzazepinone compound |
05/22/2009 | WO2009063987A1 Novel use of processed ginseng |
05/22/2009 | WO2009063248A2 Polymorphic forms of tegaserod glutarate |
05/22/2009 | WO2009063247A1 Novel crystalline forms |
05/22/2009 | WO2009063221A2 Methods of treating or preventing inflammatory diseases of the intestinal tract |
05/22/2009 | WO2009062737A1 Silibinin component for the treatment of hepatitis |
05/22/2009 | WO2009027852A3 Methods and compositions for treating gastrointestinal conditions |
05/22/2009 | WO2008068593A8 Motilide polymorphs |
05/22/2009 | WO2008040548A3 Treatment for non-alcoholic-steatohepatitis |
05/22/2009 | CA2705916A1 Benzazepinone compound |
05/22/2009 | CA2705642A1 Methods of treating or preventing inflammatory diseases of the intestinal tract |
05/22/2009 | CA2704957A1 Compositions for the treatment of gastrointestinal inflammation |
05/22/2009 | CA2704949A1 Gastrointestinal delivery systems |
05/22/2009 | CA2704946A1 Compositions for the treatment of inflammation of the gastrointestinal tract |
05/22/2009 | CA2704943A1 Compositions for the treatment of gastrointestinal inflammation |
05/22/2009 | CA2703834A1 Silibinin component for the treatment of hepatitis |
05/21/2009 | US20090131513 Anti-inflammatory modalities |
05/21/2009 | US20090131484 Preventive or remedy for bowel disease |
05/21/2009 | US20090131478 Growth Hormone Secretagogues |
05/21/2009 | US20090131471 Compositions useful for treating gastroesophageal reflux disease |
05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
05/21/2009 | US20090131453 Benzylpiperazine derivatives as motilin receptor antagonists |
05/21/2009 | US20090131418 Spiroazacyclic compounds as monoamine receptor modulators |
05/21/2009 | US20090131404 Combinations |
05/21/2009 | US20090131386 Compositions for the treatment of inflammation of the gastrointestinal tract |
05/21/2009 | US20090131364 Bioactive fraction from zingier officinale and a process for the preparation thereof |
05/21/2009 | US20090131350 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
05/21/2009 | US20090131343 Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases |
05/21/2009 | US20090131341 Novel Dihydropseudoerythromycin Derivatives |
05/21/2009 | US20090131330 Par-2 agonist |
05/21/2009 | US20090131302 Transient receptor potential vanilloid 1 and uses thereof |
05/21/2009 | US20090130762 Activation of HCV-specific T cells |
05/21/2009 | US20090130225 Macrolides derivatives as antibacterial agents |
05/21/2009 | US20090130203 Extracts of chenopodium ambrosioides l., the compositions comprising said extracts, the preparing process and application thereof |
05/21/2009 | US20090130184 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
05/21/2009 | US20090130145 Vaccine |
05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
05/21/2009 | US20090130077 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
05/21/2009 | US20090130063 Process for separating and determining the viral load in a pancreatin sample |
05/21/2009 | US20090130062 Novel Application of Heparin-Binding Epidermal Growth Factor-Like Growth Factor for Medical Purposes |
05/20/2009 | EP2060266A1 Y4 selective receptor agonists for therapeutic interventions |
05/20/2009 | EP2060265A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
05/20/2009 | EP2060255A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
05/20/2009 | EP2060183A2 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
05/20/2009 | EP2059247A1 Method and composition for promoting gastrointestinal bicarbonate secretion |
05/20/2009 | EP2059241A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
05/20/2009 | EP2059234A1 Method for reducing or alleviating inflammation in the digestive tract |
05/20/2009 | EP2059138A1 Polyphenol extraction process |
05/20/2009 | EP2059136A1 Apples with high polyphenolic content |
05/20/2009 | EP1807423B1 Quinolinone-carboxamide compounds |